Dr. Su Myat Han is an Assistant Professor specializing in infectious disease epidemiology and global health policy. She holds multiple qualifications including MBBS, MHSc, DTM&H, and PhD. With extensive field experience at Médecins Sans Frontières (MSF) spanning clinical practice, advocacy, and management, she now focuses on academic teaching and capacity-building programs across Southeast Asia. Education: MBBS (Bachelor of Medicine, Bachelor of Surgery) MHSc (Master of Health Science) DTM&H (Diploma in Tropical Medicine & Hygiene) PhD (Doctor of Philosophy) Her research examines tropical diseases, respiratory viruses, and health policy challenges in resource-limited settings. She leads courses including the Diploma in Tropical Medicine and Hygiene, Infectious Disease Epidemiology and Modeling, and Vaccinology: Science and Public Health. Her publications demonstrate consistent focus on outbreak dynamics, disease transmission patterns, and healthcare system assessments in Southeast Asia. Recent work explores influenza phylogenetics, leptospirosis interventions, COVID-19 public health measures, and stroke epidemiology in Myanmar. She maintains active research collaborations across Japan and Southeast Asia, with particular interest in understudied public health challenges affecting vulnerable populations.
Dr. Malte Vetterlein is an Associate Professor (Privatdozent) at the University Medical Center Hamburg-Eppendorf (UKE), specializing in urology with a focus on reconstructive procedures and uro-oncology. He serves at the Clinic and Polyclinic for Urology, where he conducts extensive research and clinical work in urethral reconstruction, gender-affirming surgery complications, and urological oncology. Dr. Vetterlein's research interests span several critical areas in modern urology, with particular emphasis on reconstructive urology, urethral surgery, and uro-oncology. His work addresses complex challenges in post-prostatectomy complications, urethral stricture management, and gender-affirming surgical procedures. He has developed significant expertise in patient-reported outcomes research, antimicrobial stewardship in reconstructive procedures, and innovative surgical techniques for complex urological conditions. His research has helped advance understanding of long-term outcomes following reconstructive procedures and has contributed to evidence-based guidelines in the field. Dr. Vetterlein has been prolific in scholarly output, with 153 publications documented in the UKE Research Portal. His recent work (2023-2025) demonstrates a strong focus on practical clinical challenges in reconstructive urology, with particular attention to patient-centered outcomes. He frequently collaborates with the EAU Young Academic Urologists Working Party on reconstructive urology topics, contributing to consensus statements and clinical guidelines. His publications span original research articles, systematic reviews, and editorial contributions to major urology journals. Dr. Vetterlein actively contributes to the advancement of urological practice through his work on standardized complication reporting, surgical technique refinement, and evidence-based approaches to complex reconstructive cases. His research has practical implications for improving surgical outcomes and patient satisfaction in challenging reconstructive scenarios.
Matthew D. Riedel, MD is an Assistant Professor of Orthopaedics & Rehabilitation at Yale School of Medicine. He serves as the Yale Orthopaedic Hip Fracture Program Committee Surgical Chair and Co-Director of Yale Department of Orthopaedics and Rehabilitation Resident Research. Dr. Riedel is a board-certified orthopaedic surgeon specializing in orthopaedic trauma surgery, treating injuries from car crashes, industrial accidents, and falls across all age groups from children to geriatric patients. Dr. Riedel's educational background includes: MD from Columbia University College of Physicians & Surgeons (2013) Residency in Orthopaedic Surgery at Harvard Combined Orthopaedic Residency Program (2014-2018) Chief Resident at Harvard Combined Orthopaedic Residency Program (2018) Post-Doctoral Clinical Fellowship in Orthopaedic Traumatology at R. Adams Cowley Shock Trauma Center/University of Maryland Medical Center (2019) BA in Biology & Psychology from Washington University in St. Louis (2008) Dr. Riedel's research focuses on clinical outcomes for patients with bone fractures, both operatively and nonoperatively treated, with particular interest in improving the biomechanics of surgical implants. His work examines how material properties of implants can better match bone to enhance healing and patient comfort. His research is driven by daily clinical experiences, where he constantly seeks to improve patient outcomes through better implants and surgical techniques. Dr. Riedel has published extensively in prestigious journals including Injury and The Journal of American Academy of Orthopaedic Surgeons, with recent work focusing on hip fracture fixation, infection prevention in orthopaedic trauma, and biomechanical analysis of fracture fixation techniques. Dr. Riedel's recent publications demonstrate a strong focus on orthopaedic trauma, particularly in hip and femur fractures, surgical techniques, and infection prevention. His research spans clinical outcomes studies, biomechanical analyses, and innovative approaches to fracture management. Key trends in his work include optimizing surgical techniques for hip fracture fixation, developing better methods for assessing fracture healing, and improving infection prevention strategies in orthopaedic trauma cases. Dr. Riedel has received numerous honors and recognitions: Fellow, American Academy of Orthopaedic Surgeons (2023) Finalist Nominee for Leonard Tow Humanism in Medicine Award (2021) Finalist Nominee for Charles W. Bohmfalk Faculty Teaching Award (2020) Best Clinical Paper and Best Clinical Research Paper (2018) Kilfoyle Award, 2nd Place (2018) and 3rd Place (2016) As an educator, Dr. Riedel serves as Co-Director of Yale Department of Orthopaedics and Rehabilitation Resident Research and as Department of Orthopaedics & Rehabilitation Representative on the Yale Graduate Medical Education Resident Well-Being Committee. He is actively involved in mentoring residents and has served on the Harvard Combined Orthopaedic Residency Program New Resident Selection Committee (2017-2018). His commitment to teaching has been recognized with multiple awards including finalist nominations for teaching awards at Yale. Dr. Riedel is a member of several professional organizations including the American Academy of Orthopaedic Surgeons, AOTrauma North America, and the Orthopaedic Trauma Association. He serves on the Orthopaedic Trauma Association - Practice Management Committee and is a reviewer for Injury – International Journal of the Care of the Injured and BMJ Open.
Shadi Hijjawi is an Assistant Professor in the Department of Medicine, actively contributing to medical research with a focus on oncology, pulmonology, and clinical informatics. His work spans risk prediction models, disease management, and artificial intelligence applications in healthcare. Academic Rank: Assistant Professor Department: Department of Medicine Research Interests: Dr. Hijjawi's research centers on: Breast cancer risk prediction using the Gail model Chronic obstructive pulmonary disease (COPD) exacerbations and hospital readmissions Venous thromboembolism (VTE) in cancer patients AI-driven clinical documentation and ICD coding Scientific Trends: His recent 2024 work explores generative AI models for medical coding accuracy, while earlier studies focus on Jordanian women's cancer risk, COPD management, and VTE prevention. Collaborations: Active in multi-center research with external collaborators globally.
Myles Nickolich is an Associate Professor at the Penn State University College of Medicine and serves as the Assistant Dean for Education in the Clinical Learning Environment. His research focuses on Hematology , Oncology , and Stem Cell Transplantation , particularly in improving outcomes for patients with hematological malignancies. Institution: Penn State University School: College of Medicine Department: Department of Medicine, Division of Hematology and Oncology Academic Rank: Associate Professor His work emphasizes Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) , Graft-versus-host Disease , and Leukemia Relapse prevention. Recent studies explore the role of Post-transplant Cyclophosphamide and Chimerism Testing in managing transplant complications. Scientific Awards: Dean's Award for Excellence in Teaching (2021) Dr. Nickolich's research trends highlight advancements in Transplantation Medicine , Immunotherapy , and Diagnostic Oncology . His collaborations span institutions and focus on improving survival rates and reducing relapse risks post-transplantation.
Dr. Jonathan Nunez is an Associate Professor in the Division of Infectious Diseases within the Department of Medicine at an academic medical institution. His work spans clinical practice, research, and education with a focus on addressing health disparities in addiction medicine and HIV care. His educational background includes: Infectious Disease Fellowship, University of Pennsylvania Health System (Penn Medicine), completed in 2015 Internal Medicine Residency, Yale-New Haven Medical Center, completed in 2011 MD, University of Connecticut School of Medicine, completed in 2008 Dr. Nunez's research focuses on addiction medicine and health equity in medical education. Specifically, he has academic interests in improving access to medications for opioid use disorder (MOUD), HIV primary care and prevention services. His work contributes to UN Sustainable Development Goals related to health and education. His clinical interests include medical and resident education, HIV primary care and HIV prevention services. His publication record shows significant research output from 2021-2025, with work spanning addiction medicine (particularly buprenorphine treatment protocols), HIV prevention (especially PrEP implementation), advanced diagnostic techniques for HIV, and high-impact meta-analyses on COVID-19 vaccine effectiveness. His research employs diverse methodologies including randomized clinical trials, systematic reviews, and novel diagnostic technology development. Dr. Nunez has garnered significant scholarly attention, with his 2022 meta-analysis on COVID-19 vaccine effectiveness receiving 192 Scopus citations and being referenced in policy sources. His work has been widely disseminated through numerous news outlets and social media platforms, with some publications generating hundreds of mentions across Twitter and other channels.
Jo-Anne H Young serves as a Professor in the Department of Infectious Disease and International Medicine at the University of Minnesota School of Medicine, specializing in Transplant and Cellular Therapy. Her research focuses on infectious complications in immunocompromised hosts, particularly hematopoietic stem cell and solid organ transplant recipients. Her primary research interests include invasive fungal infections , cytomegalovirus management , BK polyomavirus nephropathy , and antiviral resistance mechanisms . She employs advanced diagnostic approaches including molecular assays and biomarker monitoring to address transplant-related infections. Her work significantly contributes to UN Sustainable Development Goals related to health and well-being. Professor Young has led numerous high-impact clinical trials, including Phase 3 studies on maribavir for CMV infection, fosmanogepix for invasive mold infections, and novel therapies for HPV-associated respiratory papillomatosis. Her research demonstrates consistent funding through 88 projects totaling over $100 million, with recent grants from BASILEA PHARMACEUTICA, GILEAD SCIENCES, and MEMORIAL SLOAN-KETTERING CANCER CENTER. Editor in Chief, Clinical Microbiology Reviews (American Society for Microbiology, 2012–present) She has secured continuous grant funding since 2005, with 183 total research outputs including 121 articles, 27 reviews, and 16 editorials. Her work shows strong collaboration networks across transplant centers globally, with significant focus on viral pathogenesis and antimicrobial resistance in immunocompromised populations.
Steven A John serves as Associate Professor in the Department of Family Medicine and Community Health at the University of Minnesota, with research spanning HIV prevention, rural health disparities, and global women's health. His work directly addresses UN Sustainable Development Goals through community-focused interventions and epidemiological studies. Primary research domains include: HIV prevention strategies and PrEP accessibility for sexual minorities Health outcomes optimization for rural older adults living with HIV Cervical cancer screening implementation in resource-limited settings Rural healthcare delivery systems and telemedicine applications Recent publications demonstrate methodological diversity across scoping reviews, community-based cross-sectional studies, and clinical intervention trials. His 2024-2025 work shows concentrated focus on United States rural populations (particularly sexual minorities) and Ugandan community health settings, with strong emphasis on health equity and access barriers. Key journals include Journal of Rural Health , AIDS and Behavior , and BMC Women's Health . Current NIH-funded projects highlight translational impact: Testing Efficacy of Interventions for Rural Older Adults with HIV (2025-2027): Developing remote care models to improve quality of life Optimizing HIV/Syphilis Screening in Youth (2025): Community-level intervention at Medical College of Wisconsin His scholarly network emphasizes cross-institutional collaboration (University of Minnesota, Medical College of Wisconsin, Ugandan institutions) and interdisciplinary teams spanning public health, geriatrics, and infectious disease specialties.
Timothy L Pruett is a Professor in the Department of Surgery and holds a secondary appointment in the Division of Gastroenterology, Hepatology and Nutrition within the Department of Medicine at the University of Minnesota Medical School. His primary focus is transplant surgery, specializing in liver and pancreas transplantation, with significant contributions to clinical practice and research in organ transplantation. Dr. Pruett's research spans critical areas in transplantation medicine, with primary interests in Transplant Surgery focusing on Liver Transplantation and Pancreas Transplantation . He investigates Transplant Infectious Diseases and Transplant Immunology , particularly vaccine responses in immunocompromised patients, and applies advanced technologies to improve Surgical Outcomes . His fingerprint analysis highlights expertise in pancreatectomy, liver transplantation, infection management, and autotransplantation. His 2025 publications demonstrate a strong emphasis on advancing liver transplantation through predictive modeling, AI-driven sarcopenia assessment, and infectious disease management. Key trends include developing clinical decision tools like MELDPredict, optimizing vaccine strategies for transplant recipients, and improving organ preservation techniques. Scientific Awards: No awards listed in the provided information. Research Grants: Dr. Pruett leads multiple active research projects funded by NIH, NSF, and industry partners: CMVIG prophylaxis in belatacept conversion kidney transplant recipients : KAMADA, INC. (2024-2034) Cryopreservation and nanowarming for whole liver banking : NIH-funded (2023-2027) NetEthics: Responsible Conduct in Research Networks : NSF project (2022-2025) Timed Measurements of Plasma Iohexol Clearance : American Society of Transplant Surgeons (2023-2024) Safety of SARS-COVID-19 Vaccine in Transplant Recipients : NATERA, INC. (2021-2022) With 16 total projects (3 active, 13 completed), his work demonstrates leadership in clinical innovation and transplantation science. Laboratory Affiliation: Dr. Pruett is integral to the Advanced Technologies for Preservation of Biological Systems (ATP-BIO) initiative, which develops cutting-edge organ preservation methods through interdisciplinary collaboration between engineers, clinicians, and scientists.
Roderick Clark, MD, MSc is an Assistant Professor with dual appointments in the Department of Urology and Department of Public Health Sciences at Penn State University, where he is also affiliated with the Penn State Cancer Institute's Cancer Control program. As a fellowship-trained Surgical Oncologist specializing in urologic cancers, Dr. Clark maintains an active clinical practice with comprehensive expertise in prostate cancer management across the entire care continuum from screening to end-of-life care. Penn State Cancer Institute, Cancer Control Department of Urology Department of Public Health Sciences Dr. Clark's educational background includes a Doctor of Medicine and Master of Science in Community Health and Epidemiology from Dalhousie University, followed by residency at Western University of Western Ontario, and dual fellowships in Urologic Oncology at the University of Toronto and in Familial Breast Cancer Research at Women's College Research Institute. His research program focuses on the epidemiology, genetics, and clinical management of urologic cancers, with particular emphasis on prostate cancer. Dr. Clark investigates how to better identify and treat individuals at high-risk of dying from prostate cancer and analyzes changing population-level trends in urologic cancers using large administrative databases. His research output shows increasing productivity with 9 publications in 2022 alone, totaling 31 research outputs to date. Dr. Clark has received six teaching awards during his training, including the University of Toronto MD Teaching Excellence Award and multiple University of Western Ontario teaching recognitions. He serves as a problem-based learning facilitator at the Penn State Health Milton S. Hershey Medical Center and actively participates in the Department of Urology's educational mandate. University of Toronto MD Teaching Excellence Award University of Western Ontario Resident Teaching Award (awarded three times) UWO Class of Meds' 49 Award for Excellence in Teaching by a Resident UWO Department of Surgery Dr. Murray Girotti Award for Best Resident Teacher Annual Symposium Best Student Poster award Dalhousie Medical Research Development Office Payzant award Clinically, Dr. Clark has advanced training in numerous specialized techniques including MRI and micro-ultrasound targeted prostate biopsy, transperineal prostate biopsy, focal therapies for prostate cancer (with emphasis on high-intensity focused ultrasound), SpaceOAR hydrogel administration, robotic prostate cancer surgery, and salvage pelvic lymph node dissection/metastatectomy. He maintains board eligibility with the American Board of Urology and is a Fellow of the Royal College of Surgeons of Canada.
Dr. Michelle DeDeo is a Professor in the Department of Mathematics & Statistics at the University of North Florida (UNF), with a Research Collaborator affiliation at Mayo Clinic-Jacksonville since 2017. Her career spans 25 years at UNF, progressing from Assistant Professor (1998-2005) to Associate Professor (2005-2022) and Professor since 2022. She teaches graduate and undergraduate courses in Data Science, Number Theory, and Mathematics, with class sizes ranging from 35 to 140 students. PhD in Mathematics (1998) from University of California - San Diego Advisor: Audrey Terras (UCSD) Key collaborators: Joseph Free, Matthew Thomas, Mayo Clinic physicians Her research integrates Data Science, Computational Science, and Number Theory across diverse domains: Opioid Crisis Analysis: DEA's ARCOS database, 'Opioid Deaths Pre- and Post-COVID' (with FL-DSSG program) Graph Theory: Transposition graphs, Heisenberg graphs, Ramanujan bounds Medical Applications: Preictal seizure detection (gamma band analysis), knee surgery readmission risk factors Mathematical Physics: Toda lattice generalizations, heat equations on finite Poincare planes Recent publications demonstrate interdisciplinary impact: 2025 Physica Scripta paper on multidimensional integrable systems 2025 J Community Health Nursing influenza outbreak management study 2023 Geriatric Nursing analysis of elderly digital communication Scientific recognition includes: Outstanding Undergraduate Teaching Award (2024, 2018) Dean's Fellowship (2020) for opioid research $1.6M TQP Grant (Co-PI, 2019-2024) for teacher development She has led 25+ independent studies and theses, advised FL-DSSG program since 2020, and served on multiple university committees including Academic Standards and Graduate Committee. Her 38 MathSciNet reviews highlight ongoing scholarly engagement.
Jacques LACROIX is a Professor at the Faculty of Medicine , University of Montreal , specialized in Pediatric Intensive Care and Transfusion Medicine . With over 200 peer-reviewed publications and 74 research grants totaling CAD $39,930,284, he leads studies on Multiple Organ Dysfunction Syndrome , Anemia , and Blood Transfusion Safety in critically ill children. Founded the PALISI Network (70+ pediatric ICUs) Developed the PELOD clinical scoring system for MODS severity Research Trends : 15-year focus on blood transfusion optimization in pediatrics, with recent projects examining PICU discharge safety , transfusion thresholds , and HBV/HIV screening in blood donors. His 2015 New England Journal of Medicine study on blood storage duration remains highly cited. Scientific Awards : PALISI Leadership Award (2014) Prix Alan Ross (2013) Fondation des étoiles Career Prize (2009) University of Montreal Teaching Excellence (2002-2007) Advises 20+ graduate students across disciplines, with particular focus on hematology , critical care , and clinical trial design . Current projects include post-PICU home discharge safety (2023-2027), transfusion conservation strategies (2023-2025), and blood donor eligibility expansion (2020-2025).
Jill M. Cholette, M.D., is a Professor in the Department of Pediatrics (Critical Care) at the University of Rochester School of Medicine and Dentistry. Her research focuses on thrombosis, hemostasis, and blood product utilization in critically ill pediatric patients, particularly those undergoing cardiac surgery or requiring extracorporeal membrane oxygenation (ECMO). She also investigates the role of inflammation in thrombotic disorders and develops anticoagulation strategies for postoperative care. Education: MD | University of Rochester School of Medicine/Dentistry (USA), 1999 Residency & Fellowship | University of Rochester Medical Center Clinical Expertise: Pediatric Critical Care Pediatric Cardiology Her research integrates pediatric hematology, critical care medicine, and cardiac surgery , with a particular emphasis on optimizing transfusion practices and understanding thrombosis mechanisms in neonates and infants. She leads multi-center trials like the PROTRACT Study and CRETE Protocol , aiming to standardize prophylaxis against catheter-associated thrombosis. Dr. Cholette is an active scientific reviewer for journals such as The Annals of Thoracic Surgery and Thrombosis Research , and participates in networks like the International Pediatric Acute Lung Injury and Sepsis Network (PALISI) and the Pediatric Blood Research Network (BLOOD NET) . Her extensive work has contributed to consensus guidelines on RBC transfusion practices in pediatric ICU settings. Key Scientific Awards: Therapeutics Specialty Award (2012) Strong Children's Research Center New Investigator (2007-2010) Alpha Omega Alpha Honors Medical Society (1999) Abbey Howe Turner Award (1992) Sigma Xi, The Scientific Research Society (1995) She has published extensively in journals like JAMA , NEJM , and Pediatric Critical Care Medicine , with recent studies addressing platelet transfusion practices in ECMO and hemostatic biomarkers in cardiac surgery. Her work bridges clinical practice, research, and education in pediatric critical care.
Wenche Haugen is an Assistant Professor at the Department of Public Health and Nursing , Norwegian University of Science and Technology (NTNU). Her research focuses on mental health diagnostics and preventive medicine, with a particular emphasis on adolescent depression and post-menopausal urinary tract infections. Academic Rank: Assistant Professor Institution: Norwegian University of Science and Technology Contact: wenche.haugen@ntnu.no Research Highlights Dr. Haugen's work centers on: Validation of psychological assessment tools for depression diagnosis Clinical studies in primary health care settings Health disparities among ethnic minority adolescents Preventive strategies for urinary tract infections in post-menopausal women Her publications demonstrate cross-disciplinary collaboration with researchers like Ole Rikard Haavet and Olav Spigset.
Inês Fronteira is an Assistant Professor with Tenure at the Department of Health Systems Policy and Management, Escola Nacional de Saúde Pública (ENSP) of NOVA University of Lisbon. Her research focuses on health policy and systems, particularly the health workforce and strategies to enhance access, efficiency, and quality of care using epidemiological methods. PhD in International Health (NOVA University of Lisbon, 2011) Qualification in Public Health – Epidemiology (ENSP NOVA, 2022) Master in Public Health (ENSP NOVA, 2003) Bachelor in Nursing (Escola Superior de Enfermagem de Lisboa, 2000) Her work includes empirical evaluations of strategic planning in health workforce education and policy implementation. Recent publications address physician retention incentives, vaccination coverage, burnout mitigation, and hospital prevention policies across Europe and Brazil. President of the Portuguese Epidemiology Association Advisor to the National Ethics Council for Life Sciences (CNECV) since 2021 Member of the European Health Management Association’s Scientific Advisory Committee since 2023
